Impact of Tafamidis on Echocardiographic Cardiac Function of Patients With Transthyretin Cardiac Amyloidosis
Authors:
Open Access
- 24 March 2023
- journal article
- research article
- Published by Japanese Circulation Society in Circulation Journal
- Vol. 87 (4) , 508-516
Abstract
Background: The efficacy of a therapy for patients with transthyretin amyloid cardiomyopathy (ATTR-CM) has not been proven, but tafamidis has been associated with favorable outcomes. However, echocardiographic details of the association of tafamidis with cardiac morphology remain undetermined. Moreover, whether the efficacy of tafamidis varies with the degree of cardiac involvement remains unknown. Using echocardiography, this study investigated the impact of tafamidis on the cardiac morphology of patients with ATTR-CM.Methods and Results: Of 52 consecutive patients with biopsy-proven ATTR-CM at Kobe University Hospital, we included 41 for whom details of follow-up echocardiographic examinations after the administration of tafamidis were available. All patients underwent standard and speckle-tracking echocardiography before and a mean (±SD) of 16±8 months after the administration of tafamidis. No significant changes were observed in any representative echocardiographic parameters after the administration of tafamidis. Furthermore, there were no significant changes observed in subgroup analyses (e.g., left ventricular [LV] ejection fraction ≥50% vs. <50%; LV mass index <150 vs. ≥150 g/m2; New York Heart Association Class I–II vs. Class III; age ≥80 vs. <80 years).Conclusions: Tafamidis may prevent worsening of various representative echocardiographic parameters of patients with ATTR-CM. This effect is also seen in patients with relatively advanced disease and in those who are elderly.Keywords
This publication has 24 references indexed in Scilit:
- Systemic amyloidosisThe Lancet, 2016
- Heart Failure Resulting From Age-Related Cardiac Amyloid Disease Associated With Wild-Type TransthyretinCirculation, 2016
- Wild-type transthyretin amyloidosis as a cause of heart failure with preserved ejection fractionEuropean Heart Journal, 2015
- Recommendations for Cardiac Chamber Quantification by Echocardiography in Adults: An Update from the American Society of Echocardiography and the European Association of Cardiovascular ImagingEuropean Heart Journal - Cardiovascular Imaging, 2015
- Relative apical sparing of longitudinal strain using two-dimensional speckle-tracking echocardiography is both sensitive and specific for the diagnosis of cardiac amyloidosisHeart, 2012
- Long-term survival after liver transplantation in patients with familial amyloid polyneuropathyNeurology, 2012
- Natural history of transthyretin Val30Met familial amyloid polyneuropathy: analysis of late-onset cases from non-endemic areasJournal of Neurology, Neurosurgery & Psychiatry, 2012
- Senile Systemic Amyloidosis Presenting With Heart FailureArchives of internal medicine (1960), 2005
- The premortem recognition of systemic senile amyloidosis with cardiac involvementThe American Journal of Medicine, 1996
- Echocardiographic assessment of left ventricular hypertrophy: Comparison to necropsy findingsThe American Journal of Cardiology, 1986